Navigation Links
Nuvilex, Inc. Announces Positive Oraphyte(TM) Microplot Results
Date:9/14/2009

in the number of nematodes that remained in the soil upon the completion of the experiment. In addition, Oraphyte(TM), as determined by measuring the mean cumulative turfgrass clipping weights, does not appear to be phytotoxic to turfgrass. The cumulative grass clipping weights of microplots that received Oraphyte(TM) were not statistically different from the controls that received no pesticide and no nematodes. The final report on the LSU Phase 2 microplot trials will be issued on or before October 31, 2009.

"The transition from laboratory to commercial testing for Oraphyte(TM) is a very important step in the product's evolution to market launch," stated Martin Schmieg, Chairman and Chief Executive Officer of Nuvilex, Inc. "The demand for an all-natural, eco-friendly nematocide amongst golf course superintendents and farmers continues to increase as the number of EPA-registered synthetic nematocides decreases. We anticipate, with continuing positive test results, that the market acceptance of Oraphyte(TM) as a major product in the new eco-friendly pesticide market will be strong."

About Oraphyte(TM)

Oraphyte(TM) is an all-natural, eco-friendly, biodegradable nematocide for turfgrass and high-value crops. Oraphyte(TM) can be formulated as a liquid or solid and is composed of orange terpene oil, Valencia orange oil, hydrogen peroxide, sorbitan monooleate, and distilled water. All of Oraphyte's ingredients are listed on the Office of Prevention, Pesticides, and Toxic Substances (OPPTS) of the United States Environmental Protection Agency's (EPA) inert ingredient list.

From 2007 to 2009, Oraphyte has undergone testing at Louisiana State University, Auburn University, the University of Florida, Ohio State University, and the USDA to determine its efficacy and usefulness as a non-toxic, low-cost alternative to many traditional nematocides, including Nemacur, Curfew, Telone II, and Temi
'/>"/>

SOURCE Nuvilex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Nuvilex, Inc. Announces Reme-Flu(TM) as Trade Name for All-Natural Flu Remedy Formula
2. Nuvilex, Inc. Finalizes Joint Venture Agreement for the Development of Broad Spectrum All-Natural Flu Remedies
3. The KonLin Letter Issues Featured Stock Update on Nuvilex, Inc. in Its September 2009 Edition
4. Nuvilex, Inc. Sets Times and Locations for Upcoming Shareholder Meetings
5. Nuvilex, Inc. Announces Business Update Conference Call
6. Nuvilex, Inc. Announces Monthly Investor Conference Call
7. Nuvilex, Inc. Announces Investor Conference Call and Open House
8. Nuvilex, Inc.s Marketing Partner, CK41 to Launch purEffect(TM) in May
9. Nuvilex, Inc. Announces New Pricing for Cinnergen and Launch of dLife Advertising and Promotion Campaign
10. Nuvilex, Inc. Launches Spring Break Initiatives Designed to Raise Visibility Among Key Demographic Group
11. eFoodSafety.com, Inc. Changes Name to Nuvilex, Inc., Reflecting New Strategic Direction of Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 Power Systems is proud ... the 2015 race season. Drobeck is in his second year ... a firefighter with the Missoula Fire Department in Missoula, MT. ... Pro in 2014. During his career, he has had 15 ... Drobeck recorded top 10 finishes in all seven of his ...
(Date:5/22/2015)... May 22, 2015 ZH ... IT solutions, announced today that Bill Lane, joins ... the developer of BlueEHS,a first of its kind, ... a customizable Electronic Health Records (EHR) with an ... a telemedicine-enabled comprehensive patient portal, and more. Combined ...
(Date:5/22/2015)... West Hollywood, CA (PRWEB) May 22, 2015 ... at Sunset Plaza Dental announces that they ... in cosmetic, restorative and other dental treatments. At ... that interest them. Questions regarding what certain treatments ... can also be covered during this initial appointment. ...
(Date:5/22/2015)... May 22, 2015 Medivo, Inc., a leader ... Rates and Genotype Results in ‘Baby Boomers’ Screened for HCV ... Nationwide Lab Test Database” at Digestive Disease Week, May 16-19, ... Affairs and Analytics team members Carol Smyth, MB; Jason Bhan, ... Parker, MSI, along with Nancy Reau, MD from the University ...
(Date:5/22/2015)... A Phase 3 French study, which ... Clinical Oncology (ASCO)’s annual meeting at the end ... patients who received bevacizumab in addition to the ... Genentech, Inc.) is an antibody that blocks angiogenesis ... used to treat many other cancers, including lung ...
Breaking Medicine News(10 mins):Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2
... that one particularly aggressive type of blood cancer, mixed lineage ... motors running. The cancer cells rely on the normal version ... happens when a piece of chromosome 11 breaks off at ... another chromosome, resulting in a fusion protein that eventually causes ...
... 2, 2010 Researchers at UT Southwestern Medical Center hope ... against drug dependence. Their hypothesis that increasing the normally ... is based on a rodent study demonstrating that blocking new ... addiction and relapse. The study,s findings, available in the ...
... ... releases Meaningful Use Dashboard for Health Systems. The Meaningful Use Dashboard will provide a ... in regards to Meaningful Use Indicators. , ... Columbus, OH (PRWEB) February 26, 2010 -- Health Care ...
... play key role, study finds , FRIDAY, Feb. 26 (HealthDay ... antibodies may contribute to the development of heart disease in ... is an autoimmune illess in which the immune system creates ... that results in damage to tissue and organs, including the ...
... led to 30 percent reduction in lost tissue, study found ... flow of blood to the heart by repeatedly inflating a ... damaged during a heart attack, a new Danish study shows. ... a hospital for treatment of severe heart attacks, the amount ...
... ... a leading medical informatics company, has signed a strategic partnership agreement with Medical ... easy to deploy diagnostic capability across the healthcare enterprise. , , ... Milwaukee (PRWEB) ...
Cached Medicine News:Health News:Cells of aggressive leukemia hijack normal protein to grow 2Health News:Increasing neurogenesis might prevent drug addiction and relapse 2Health News:HCD Announces Meaningful Use Dashboard for Health Systems 2Health News:New Clues to Lupus' Link With Heart Disease 2Health News:Cutting Off Blood Flow to Heart Limits Damage During Heart Attack 2Health News:Cutting Off Blood Flow to Heart Limits Damage During Heart Attack 3Health News:TeraMedica Inks Reseller Agreement With Medical Insight Enterprise Image Viewer Company 2Health News:TeraMedica Inks Reseller Agreement With Medical Insight Enterprise Image Viewer Company 3
(Date:5/22/2015)... May 20, 2015 Research and Markets( ... "Guide to Prepare Application Dossiers for Oversea ... Edition) " report to their offering. ... of segment market of the most growth potentiality, ... device manufacturers and producers to penetrate such market. ...
(Date:5/22/2015)... , May 22, 2015 Today, ... central nervous system stimulant indicated for the treatment ... patients beginning Summer 2015. The ... received approval from the U.S. Food and Drug ... an extended-release formulation of methylphenidate capsule with an ...
(Date:5/22/2015)... 22, 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... chief executive officer Howie Rosen will be ... officer Tim Morris will be presenting at ... presentations are as follows: Jefferies 2015 Healthcare ...
Breaking Medicine Technology:China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2
... , July 26 Perrigo Company (Nasdaq: PRGO ... the U.S. Food and Drug Administration to manufacture and market over-the-counter ... fiscal first quarter 2011. Cherry joins the currently available grape flavor ... store brand flavors. , , ...
... July 26 Halt Medical, Inc. announced today ... appointed to its Scientific Advisory Board.  Dr. Rubin will ... develop and implement comprehensive reimbursement strategies.  Dr. Rubin,s distinguished ... medicine, government, and business. Currently, he is Clinical Professor ...
Cached Medicine Technology:Perrigo Announces FDA Approval for Over-the-Counter Cetirizine Cherry Syrup 2Perrigo Announces FDA Approval for Over-the-Counter Cetirizine Cherry Syrup 3Dr. Robert J. Rubin to Join Halt Board as Reimbursement Advisor 2
... used to evaluate both low contrast acuity and ... 12.5%) of LogMAR acuity (20/16 to 20/100) are ... the two spatial frequencies of 6 and 12 ... cataract documentation because eye doctors can document cataract ...
... test face is widely used for in or ... presents standard visual acuity from 20/15 to 20/200, ... cycles/degree) and a real-world driver's scene. , ,The ... it provides a standard acuity score, a functional ...
The compact, simple-to-use ECG for medical professionals....
The first book to translate key medical data into clear guidelines capturing the highest treatment standards for heart disease....
Medicine Products: